[Thymostimulin immunoprophylaxis in elective abdominal surgery].
The Authors report their experience of 121 patients who had undergone an elective abdominal operation and who had been previously considered under an immunological point of view and classified as anergic. The Authors have found a notable reduction of postoperative infection incidence in the 61 anergic operated patients who have been treated with Thymostimulin; they conclude by underlining the importance of careful consideration and eventual correction of immunological alterations of the patients of the patients who must undergo an operation.
Perotti
F
F
Divisione di Chirurgia Generale, USSL 54 Borgomanero, Novara.
Landi
G
G
Primatesta
F
F
Colombo
A
A
David
P G
PG
Castellaro
E
E
Baraldi
U
U
D000005:Abdomen / Q000601:surgery*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011182:Postoperative Care; D011300:Preoperative Care; D012882:Skin Tests; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013949:Thymus Extracts; C031407:thymostimulin
Immunoprofilassi con timostimolina in chirurgia addominale d'elezione.